Cutera, Inc. (CUTR) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

7.95 k

Shareholding (Sep 2024)

FII

7.80%

Held by 57 FIIs

DII

51.01%

Held by 42 DIIs

Promoter

3.76%

How big is Cutera, Inc.?

22-Jun-2025

As of May 02, Cutera, Inc. has a market capitalization of $0.17 million, with net sales of $155.21 million and a net profit of -$131.71 million over the last four quarters. The company reported shareholder's funds of -$171.83 million and total assets of $346.29 million as of December 23.

Should I buy, sell or hold Cutera, Inc.?

22-Jun-2025

Who are in the management team of Cutera, Inc.?

22-Jun-2025

As of March 2022, the management team of Cutera, Inc. includes J. Daniel Plants (Independent Chairman), David Mowry (CEO and Director), and independent directors Gregory Barrett, Timothy O'Shea, Joseph Whitters, and Katherine Zanotti.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

The company has declared Negative results for the last 12 consecutive quarters

DEBTORS TURNOVER RATIO(HY) Lowest at 3.43%
RAW MATERIAL COST(Y) Grown by 82.03% (YoY)
NET SALES(Q) Lowest at USD 32.5

Risky - Not traded in last 10 days

Mojo Parameters

Stock DNA

Industry

Medical Specialties

Market cap

USD 0 Million (Micro Cap)

P/E

Industry P/E

Dividend Yield

0.00%

Debt Equity

-1.45

Return on Equity

55.92%

Price to Book

-0.00

Revenue and Profits:

Net Sales:

32 Million

(Quarterly Results - Sep 2024)

Net Profit:

-39 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-98.06%

6 Months

-98.58%

1 Year

-99.68%

2 Years

-99.96%

3 Years

-99.99%

4 Years

-99.97%

5 Years

-99.94%

Cutera, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-2.42%

EBIT Growth (5y)

-245.01%

EBIT to Interest (avg)

-9.38

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-1.45

Sales to Capital Employed (avg)

0.77

Tax Ratio

0.93%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

4.10%

ROE (avg)

0.71%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

-0.00

EV to EBIT

-2.79

EV to EBITDA

-3.10

EV to Capital Employed

3.22

EV to Sales

2.36

PEG Ratio

Dividend Yield

ROCE (Latest)

-115.34%

ROE (Latest)

Negative BV

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Bearish

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2024

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 51 Schemes (37.31%)

Foreign Institutions

Held by 57 Foreign Institutions (7.8%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is -5.52% vs -11.34% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2024 is -57.89% vs -8.33% in Jun 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32.50",
          "val2": "34.40",
          "chgp": "-5.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-33.40",
          "val2": "-18.60",
          "chgp": "-79.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "3.70",
          "val2": "3.50",
          "chgp": "5.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-39.00",
          "val2": "-24.70",
          "chgp": "-57.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-1,114.40%",
          "val2": "-634.30%",
          "chgp": "-48.01%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is -15.85% vs 9.12% in Dec 2022",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -97.81% vs -4,019.05% in Dec 2022",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "212.40",
          "val2": "252.40",
          "chgp": "-15.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-145.50",
          "val2": "-29.70",
          "chgp": "-389.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "14.00",
          "val2": "7.00",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-34.40",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-162.80",
          "val2": "-82.30",
          "chgp": "-97.81%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-735.70%",
          "val2": "-151.30%",
          "chgp": "-58.44%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ

Sep'24

Jun'24

Change(%)

Net Sales

32.50

34.40

-5.52%

Operating Profit (PBDIT) excl Other Income

-33.40

-18.60

-79.57%

Interest

3.70

3.50

5.71%

Exceptional Items

0.00

Consolidate Net Profit

-39.00

-24.70

-57.89%

Operating Profit Margin (Excl OI)

-1,114.40%

-634.30%

-48.01%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Sep 2024 is -5.52% vs -11.34% in Jun 2024

Consolidated Net Profit

QoQ Growth in quarter ended Sep 2024 is -57.89% vs -8.33% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'23

Dec'23

Dec'22

Change(%)

Net Sales

212.40

252.40

-15.85%

Operating Profit (PBDIT) excl Other Income

-145.50

-29.70

-389.90%

Interest

14.00

7.00

100.00%

Exceptional Items

0.00

-34.40

100.00%

Consolidate Net Profit

-162.80

-82.30

-97.81%

Operating Profit Margin (Excl OI)

-735.70%

-151.30%

-58.44%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2023 is -15.85% vs 9.12% in Dec 2022

Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -97.81% vs -4,019.05% in Dec 2022

All Annual Results

Company CV

About Cutera, Inc.

Cutera, Inc.

Medical Specialties

Cutera, Inc. is a medical device company. The Company is engaged in the design, development, manufacture, marketing and servicing of laser and other energy-based aesthetics systems for practitioners across the world. The Company offers products based on product platforms, such as enlighten, excel HR, truSculpt, excel V and xeo, each of which enables physicians and other practitioners to perform aesthetic procedures for customers. Each of its laser and other energy-based platforms consists of one or more hand pieces and a console that incorporates a universal graphical user interface, a laser or other energy-based module, control system software and high voltage electronics. The Company also offers products, such as CoolGlide that includes CV, Excel and Vantage; Solera that includes Titan S, ProWave 770, OPS 600, LP560, AcuTip 500, Titan V/XL and LimeLight, and a third-party sourced system, myQ for the Japanese market.

Company Coordinates

Company Details

3240 Bayshore Blvd , BRISBANE CA : 94005-1021

Tel: 1 415 65755001 415 6575500

http://www.cutera.com/

Registrar Details

Cutera, Inc.

1Day

52 Week

CASH

FII

DII

Promoter

How big is Cutera, Inc.?

Watch in Real-Time

Should I buy, sell or hold Cutera, Inc.?

Who are in the management team of Cutera, Inc.?

MarketsMojo — Loved in India, Now Global

Dashboard

The company has declared Negative results for the last 12 consecutive quarters

Risky - Not traded in last 10 days

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot : Sep 2024

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Sep'24 - QoQ

Annual Results Snapshot (Consolidated) - Dec'23

About Cutera, Inc.

Company Coordinates